Minrad’s Image Guidance System is designed to enhance the safety and efficacy of fluoroscopically guided surgery and interventional procedures. The system’s image guidance technology provides continuous visual confirmation of accurate instrument orientation to assist in targeting the precise desired subcutaneous anatomy.
As the two studies within confirm, this image guidance system can reduce the need for additional fluoroscopic views to confirm instrument placement, thereby decreasing radiation exposure for physicians, medical personnel and patients.
Desflurane and Sevoflurane are the only anesthetic drugs that have been proven to reduce perioperative morbidity and mortality up to date.
A recent meta-analysis has shown a reduction in perioperative myocardial infarction (MI) and death in those patients randomized to receive Desflurane or Sevoflurane versus a total intravenous anesthesia (TIVA) for cardiac surgery.
The most recent American College of Cardiology/American Heart Association Guidelines recommend the use of volatile anesthetic agents during non-cardiac surgery for the maintenance of general anesthesia in patients at risk for MI.
The mechanisms that lie beneath the protection from perioperative cardiac ischaemic damage given by Desflurane and Sevoflurane still lack a complete explanation, although pharmacological properties which are not related to anesthetic or haemodynamic effects of these drugs appear to be involved.
Minrad manufactures both Desflurane and Sevoflurane. RxElite holds the exclusive distribution rights for Minrad produced anesthetic gases for the human market in the U.S.